Literature DB >> 18692715

Common variable immunodeficiency: a new look at an old disease.

Miguel A Park1, James T Li, John B Hagan, Daniel E Maddox, Roshini S Abraham.   

Abstract

Primary immunodeficiencies comprise many diseases caused by genetic defects primarily affecting the immune system. About 150 such diseases have been identified with more than 120 associated genetic defects. Although primary immunodeficiencies are quite rare in incidence, the prevalence can range from one in 500 to one in 500 000 in the general population, depending on the diagnostic skills and medical resources available in different countries. Common variable immunodeficiency (CVID) is the primary immunodeficiency most commonly encountered in clinical practice, and appropriate diagnosis and management of patients will have a significant effect on morbidity and mortality as well as financial aspects of health care. Advances in diagnostic laboratory methods, including B-cell subset analysis and genetic testing, coupled with new insights into the molecular basis of immune dysfunction in some patients with CVID, have enabled advances in the clinical classification of this heterogeneous disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18692715     DOI: 10.1016/S0140-6736(08)61199-X

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  89 in total

1.  Airway and interstitial lung disease are distinct entities in paediatric common variable immunodeficiency.

Authors:  A A J M van de Ven; P A de Jong; D P Hoytema van Konijnenburg; O A M Kessels; M Boes; E A M Sanders; S W J Terheggen-Lagro; J M van Montfrans
Journal:  Clin Exp Immunol       Date:  2011-06-02       Impact factor: 4.330

2.  LPS-responsive beige-like anchor (LRBA) gene mutation in a family with inflammatory bowel disease and combined immunodeficiency.

Authors:  Abdullah Alangari; Abdulrahman Alsultan; Nouran Adly; Michel J Massaad; Iram Shakir Kiani; Abdulrahman Aljebreen; Emad Raddaoui; Abdul-Kareem Almomen; Saleh Al-Muhsen; Raif S Geha; Fowzan S Alkuraya
Journal:  J Allergy Clin Immunol       Date:  2012-06-19       Impact factor: 10.793

3.  Impaired pneumovax-23-induced monocyte-derived cytokine production in patients with common variable immunodeficiency.

Authors:  Raymond Hong; Sudhanshu Agrawal; Sastry Gollapudi; Sudhir Gupta
Journal:  J Clin Immunol       Date:  2010-02-23       Impact factor: 8.317

4.  Dysregulated CD1 profile in myeloid dendritic cells in CVID is normalized by IVIg treatment.

Authors:  Dominic Paquin-Proulx; Bianca A N Santos; Karina I Carvalho; Myrthes Toledo-Barros; Ana Karolina Barreto de Oliveira; Cristina M Kokron; Jorge Kalil; Markus Moll; Esper G Kallas; Johan K Sandberg
Journal:  Blood       Date:  2013-06-13       Impact factor: 22.113

5.  Resistance to complement-mediated killing and IgM binding to non-typeable Haemophilus influenzae is not altered when ascending from the nasopharynx to the middle ears in children with otitis media.

Authors:  Jeroen D Langereis; Thijs M A van Dongen; Kim Stol; Roderick P Venekamp; Anne G M Schilder; Peter W M Hermans
Journal:  Med Microbiol Immunol       Date:  2013-06-18       Impact factor: 3.402

6.  A case of explosive progression of hepatocellular carcinoma in a patient with common variable immunodeficiency (CVID).

Authors:  Kaushang Gandhi; Purvi Parikh; Wilbert S Aronow; Harit Desai; Harshad Amin; Mala Sharma; Arye Rubinstein
Journal:  J Gastrointest Cancer       Date:  2010-12

Review 7.  Flow Cytometry, a Versatile Tool for Diagnosis and Monitoring of Primary Immunodeficiencies.

Authors:  Roshini S Abraham; Geraldine Aubert
Journal:  Clin Vaccine Immunol       Date:  2016-04-04

8.  Reduced immunoglobulin M is associated with sinus mucosal thickening, osteitis and sinus surgery in patients with common variable immunodeficiency.

Authors:  John B Hagan; Miguel A Park; Hirohito Kita; Norbert G Campeau
Journal:  Int Arch Allergy Immunol       Date:  2009-11-24       Impact factor: 2.749

9.  Reduced BAFF-R and increased TACI expression in common variable immunodeficiency.

Authors:  Rita R Barbosa; Susana L Silva; Sara P Silva; Alcinda C Melo; M Conceição Pereira-Santos; João T Barata; Lennart Hammarström; Marília Cascalho; Ana E Sousa
Journal:  J Clin Immunol       Date:  2014-05-09       Impact factor: 8.317

10.  CD46-induced human Treg enhance B-cell responses.

Authors:  Anja Fuchs; John P Atkinson; Veronique Fremeaux-Bacchi; Claudia Kemper
Journal:  Eur J Immunol       Date:  2009-11       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.